Beta Bionics, Inc. (BBNX) Net Income towards Common Stockholders (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Net Income towards Common Stockholders data on file, last reported at -$21.9 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 35.1% year-over-year to -$21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.4 million (down 34.94% YoY) and the FY2025 annual result came in at -$60.7 million, down 46.94% from the prior year.
• Net Income towards Common Stockholders declined to -$21.9 million in Q1 2026 per BBNX's latest filing, from -$13.5 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$8.3 million in Q1 2024, with the low at -$21.9 million in Q1 2026.
• Average Net Income towards Common Stockholders over 3 years is -$13.8 million, with a median of -$13.5 million recorded in 2025.
• The widest YoY moves for Net Income towards Common Stockholders: up 11.42% in 2025, down 94.92% in 2025.
• Beta Bionics' Net Income towards Common Stockholders stood at -$12.1 million in 2024, then decreased by 11.42% to -$13.5 million in 2025, then tumbled by 62.59% to -$21.9 million in 2026.
• Business Quant data shows BBNX's Net Income towards Common Stockholders at -$21.9 million in Q1 2026, -$13.5 million in Q4 2025, and -$14.2 million in Q3 2025.